Fate Therapeutics Aktie
1,34
EUR
-0,01
EUR
-0,52
%
1,41
USD
-0,14
USD
-8,74
%
Werbung
Fate Therapeutics Aktie Analyse
09.08.19 | Fate Therapeutics Buy | BTIG Research | |
22.07.19 | Fate Therapeutics Overweight | Cantor Fitzgerald | |
12.07.19 | Fate Therapeutics Outperform | Oppenheimer & Co. Inc. | |
06.03.18 | Fate Therapeutics Neutral | H.C. Wainwright & Co. | |
12.10.17 | Fate Therapeutics Buy | H.C. Wainwright & Co. | |
08.11.16 | Fate Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
15.04.16 | Fate Therapeutics Outperform | BMO Capital Markets | |
11.05.15 | Fate Therapeutics Buy | H.C. Wainwright & Co. | |
Werbung
|
Werbung
Werbung